226 related articles for article (PubMed ID: 36055727)
1. Pharmacotherapy of Opioid Use Disorder-Update and Current Challenges.
Racha S; Buresh M; Fingerhood M
Psychiatr Clin North Am; 2022 Sep; 45(3):335-346. PubMed ID: 36055727
[TBL] [Abstract][Full Text] [Related]
2. Medications for management of opioid use disorder.
Koehl JL; Zimmerman DE; Bridgeman PJ
Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
[TBL] [Abstract][Full Text] [Related]
3. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
Hughto JMW; Tapper A; Rapisarda SS; Stopka TJ; Palacios WR; Case P; Silcox J; Moyo P; Green TC
Subst Abuse Treat Prev Policy; 2023 May; 18(1):30. PubMed ID: 37217975
[TBL] [Abstract][Full Text] [Related]
4. Update on Barriers to Pharmacotherapy for Opioid Use Disorders.
Sharma A; Kelly SM; Mitchell SG; Gryczynski J; O'Grady KE; Schwartz RP
Curr Psychiatry Rep; 2017 Jun; 19(6):35. PubMed ID: 28526967
[TBL] [Abstract][Full Text] [Related]
5. Medication Treatment of Opioid Use Disorder.
Bell J; Strang J
Biol Psychiatry; 2020 Jan; 87(1):82-88. PubMed ID: 31420089
[TBL] [Abstract][Full Text] [Related]
6. Low-dose buprenorphine initiation in the era of fentanyl and fentanyl analogs: A case series of outpatient inductions.
Ahmed S; Faruqui Z; Poddar K; Bhivandkar S; Suzuki J
J Opioid Manag; 2023; 19(5):455-460. PubMed ID: 37968979
[TBL] [Abstract][Full Text] [Related]
7. Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review.
Englander H; Thakrar AP; Bagley SM; Rolley T; Dong K; Hyshka E
JAMA Intern Med; 2024 Jun; 184(6):691-701. PubMed ID: 38683591
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and current clinical practices of opioid treatment programs in the United States.
Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
[TBL] [Abstract][Full Text] [Related]
9. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.
Camenga DR; Colon-Rivera HA; Muvvala SB
J Stud Alcohol Drugs; 2019 Jul; 80(4):393-402. PubMed ID: 31495374
[TBL] [Abstract][Full Text] [Related]
10. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
[No Abstract] [Full Text] [Related]
11. METHADONE INITIATION IN THE EMERGENCY DEPARTMENT FOR OPIOID USE DISORDER: A CASE SERIES.
Huo S; Heil J; Salzman MS; Carroll G; Haroz R
J Emerg Med; 2023 Mar; 64(3):391-396. PubMed ID: 37019500
[TBL] [Abstract][Full Text] [Related]
12. Update on pharmacotherapy for treatment of opioid use disorder.
Ayanga D; Shorter D; Kosten TR
Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745
[TBL] [Abstract][Full Text] [Related]
13. News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic.
Kennedy-Hendricks A; Levin J; Stone E; McGinty EE; Gollust SE; Barry CL
Health Aff (Millwood); 2019 Apr; 38(4):643-651. PubMed ID: 30933576
[TBL] [Abstract][Full Text] [Related]
14. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Jordan CJ; Cao J; Newman AH; Xi ZX
Neuropharmacology; 2019 Nov; 158():107609. PubMed ID: 31009632
[TBL] [Abstract][Full Text] [Related]
15. The case for a medication first approach to the treatment of opioid use disorder.
Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
[No Abstract] [Full Text] [Related]
16. Pharmacological treatment of opioid use disorder in pregnancy.
Rodriguez CE; Klie KA
Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
[TBL] [Abstract][Full Text] [Related]
17. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
Xu KY; Presnall N; Mintz CM; Borodovsky JT; Bhat NR; Bierut LJ; Grucza RA
JAMA Netw Open; 2021 Feb; 4(2):e210061. PubMed ID: 33625511
[TBL] [Abstract][Full Text] [Related]
18. Medication-Assisted Treatment for Opioid-Use Disorder.
Oesterle TS; Thusius NJ; Rummans TA; Gold MS
Mayo Clin Proc; 2019 Oct; 94(10):2072-2086. PubMed ID: 31543255
[TBL] [Abstract][Full Text] [Related]
19. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
Shulman M; Weiss R; Rotrosen J; Novo P; Costello E; Nunes EV
Addict Sci Clin Pract; 2021 Mar; 16(1):15. PubMed ID: 33676577
[TBL] [Abstract][Full Text] [Related]
20. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
Andraka-Christou B; Nguyen T; Harris S; Madeira J; Totaram R; Randall-Kosich O; Atkins D; Ford J
Am J Drug Alcohol Abuse; 2020 Sep; 46(5):589-603. PubMed ID: 32543922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
